Baumann M, Overgaard J (2014) What next? Radiother Oncol 110: 1–2

Brüchner K, Beyreuther E, Baumann M, Krause M, Oppelt M, Pawelke J (2014) Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles. Radiat Oncol 9: 57

Bütof R, Kirchner K, Appold S, Löck S, Rolle A, Höffken G, Krause M, Baumann M (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190: 263–269

Dörr W, Herrmann T, Baumann M (2014) Application of organ tolerance dose-constraints in clinical studies in radiation oncology. Strahlenther Onkol 190: 621–627

Dörr W, Kallfels S, Herrmann T (2014) Response to the letter to the editor by Genc et al. Strahlenther Onkol 190: 963–964

Eke I, Ingargiola M, Förster C, Kunz-Schughart LA, Baumann M, Runge R, Freudenberg R, Kotzerke J, Heldt J-M, Pietzsch H-J, Steinbach J, Cordes N (2014) Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro. Int J Radiat Biol 90: 678–686

Gurtner K, Ebert N, Pfitzmann D, Eicheler W, Zips D, Baumann M, Krause M (2014) Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. Radiat Oncol 9: 261

Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Baumann M, Zips D, Yaromina A (2014) BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. Radiat Oncol 9: 207

Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Pruschy M, Baumann M, Yaromina A, Zips D (2014) Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. Int J Radiat Oncol Biol Phys 88: 159–166

Ingargiola M, Runge R, Heldt J-M, Freudenberg R, Steinbach J, Cordes N, Baumann M, Kotzerke J, Brockhoff G, Kunz-Schughart LA (2014) Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Int J Cancer 135: 968–980

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Antratschke N, Guckenberger M (2014) Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88: 732–738

Koi L, Bergmann R, Brüchner K, Pietzsch J, Pietzsch H-J, Krause M, Steinbach J, Zips D, Baumann M (2014) Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential. Radiother Oncol 110: 362–369

Krause M, Baumann M (2014) Reduced acute toxicity for adults with medulloblastoma treated with proton beam craniospinal irradiation. Strahlenther Onkol 190: 111–112

Linge A, Maurya P, Friedrich K, Baretton GB, Kelly S, Henry M, Clynes M, Larkin A, Meleady P (2014) Identification and functional validation of RAD23B as a potential protein in human breast cancer progression. J Proteome Res 13: 3212–3222

Lühr A, Löck S, Roth K, Helmbrecht S, Jakobi A, Petersen JB, Just U, Krause M, Enghardt W, Baumann M (2014) Concept for individualized patient allocation: ReCompare--remote comparison of particle and photon treatment plans. Radiat Oncol 9: 59

Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, Strup-Perrot C, To T-H-V, Calmels L, Germaini M-M, Gourgou S, Fenoglietto P, Bourgier C, Gomez A-M, Escoubet B, Dörr W, Haagen J, Deutsch E, Moret E, Vozenin MC (2014) Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis. Radiother Oncol 111: 63–71

Patties I, Habelt B, Rosin B, Dörr W, Hildebrandt G, Glasow A (2014) Late effects of local irradiation on the expression of inflammatory markers in the Arteria saphena of C57BL/6 wild-type and ApoE-knockout mice. Radiat Environ Biophys 53: 117–124

Philipp J, Baumann M (2014) Caution with hypofractionated dose-escalating radiotherapy in non-small cell lung cancer. Strahlenther Onkol 190: 597–599

Pirkkanen J, von Neubeck C, Sowa M (2014) Summary of an integrated experimental and computational approach to study the effects of heavy ion exposures on skin. NasaTHREE

Ramaekers BLT, Joore MA, Lueza B, Bonastre J, Mauguen A, Pignon J-P, Le Pechoux C, De Ruysscher DKM, MAR-LC Collaborative group, Grutters JPC (2013) Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients. J Thorac Oncol 8: 1295–1307

Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, Drumea K, Dunning AM, Easton D, Eeles R, Fachal L, Gutiérrez-Enríquez S, Haustermans K, Henrúques-Hernándezb LA, Imai T, Jones GDD, Kerns SL, Liao Z, Onel K, Ostrer H, Parliament M, Pharoah PDP, Rebbeck TR, Talbot CJ, Thierens H, Vega A, Witte JS, Wong P, Zenhausern F, for The Radiogenomics Consortium (2014) Radiogenomics: radiobiology enters the era of big data and team science. Int J Radiat Oncol Biol Phys 89: 709–713

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M (2015) Stereotactic body radiotherapy for centrally located stage I NSCLC : A multicenter analysis. Strahlenther Onkol 191: 125–132

Schmidt M, Haagen J, Noack R, Siegemund A, Gabriel P, Dörr W (2014) Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 190: 399–404

Schmidt M, Piro-Hussong A, Siegemund A, Gabriel P, Dörr W (2014). Modification of radiation-induced oral mucositis (mouse) by adult stem cell therapy: single-dose irradiation. Radiat Environ Biophys 53: 629–634

Schütze C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Zips D, Hessel F, Krause M, Thames H, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B (2014) Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice. Radiother Oncol 111: 81–87

Seidel N, Stoelzel F, Garzarolli M, Herrmann S, Breitbart EW, Berth H, Baumann M, Ehninger G (2013) Sun protection training based on a theater play for preschoolers: an effective method for imparting knowledge on sun protection? J Cancer Educ 28: 435–438

Sihver W, Pietzsch J, Krause M, Baumann M, Steinbach J, Pietzsch H-J (2014) Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy. Pharmaceuticals (Basel) 7: 311–338

Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M (2014) Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets. Radiother Oncol 113: 303–309

Stölzel F, Seidel N, Uhmann S, Baumann M, Berth H, Hoyer J, Ehninger G (2014) Be smart against cancer! A school-based program covering cancer-related risk behavior. BMC Public Health 14: 392

Tillner F, Thute P, Bütof R, Krause M, Enghardt W (2014) Preclinical research in small animals using radiotherapy technology - a bidirectional translational approach. Z Med Phys

Wang M, Kern AM, Hülskötter M, Greninger P, Singh A, Pan Y, Chowdhury D, Krause M, Baumann M, Benes CH, Efstathiou J, Settleman J, Willers H (2014) EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. Cancer Res 74: 2825–2834